Key Takeaways

• Developing new drugs, experimenting with formulas, and conducting clinical trials often qualify for the R&D tax credit.
• Activities focused on improving medical treatments or testing alternative production methods are strong candidates.
• Both small startups and large firms can benefit from significant tax savings.

Biotechnology and pharmaceuticals are at the forefront of innovation, and many of their activities qualify for the R&D tax credit. If you’re working on groundbreaking treatments or enhancing existing ones, there’s a good chance you’re leaving tax savings on the table.

Qualifying Activities in Biotech and Pharmaceuticals

Here are some common activities in the biotechnology and pharmaceutical industries that may qualify:

1. Drug Development
   Creating new drugs to address unmet medical needs or improve existing treatments.
2. Clinical Trials
   Conducting trials to test the safety, efficacy, or performance of new products.
3. Formulation Experimentation
   Refining formulas for better shelf life, improved efficacy, or compliance with new regulations.
4. Testing and Validation
   Experimenting with production processes or materials to improve scalability and quality.
5. Regulatory Compliance Research
   Meeting FDA or other regulatory standards often involves research that qualifies for credits.

Breaking Down the 4-Part Test for Biotech and Pharmaceuticals

Software activities can meet the R&D tax credit’s 4-Part Test:

1. Business Component Test:
   Activities like developing new drugs, treatments, or processes align with this requirement.
2. Technological in Nature Test:
   These efforts are based on life sciences, chemistry, or other hard sciences.
3. Elimination of Uncertainty Test:
   Uncertainty about drug effectiveness, production methods, or formula stability is common in this industry.
4. Process of Experimentation Test:
   Conducting trials, testing alternatives, and iterating on formulas are key components.

Related Content for Software Companies

Check out Qualified Research Expenses (QREs): Breaking Down the Basics and Common Misconceptions About R&D Tax Credits.

Claim R&D Tax Credits Today

The Research & Development Tax Credit and Biotechnology and Pharmaceuticals go hand in hand. Contact us to get started on claiming the R&D Tax Credit and reducing your tax bill today!

Examples of Qualifying Activity

Drug Discovery & Development

• Example: Researching and developing new mRNA-based vaccines and pharmaceuticals to treat infectious diseases.
• 4-Part Test:
  • Permitted Purpose: Aims to create more effective treatments with improved efficacy and safety.
  • Technological in Nature: Utilizes molecular biology, pharmacology, and computational chemistry.
  • Elimination of Uncertainty: Determines whether a new drug formulation will produce the intended immune response.
  • Process of Experimentation: Conducts preclinical lab studies, animal trials, and phased clinical trials.

Biopharmaceuticals & Biosimilars

• Example: Developing biologics and biosimilar therapies for treating chronic diseases like cancer and autoimmune disorders.
• 4-Part Test:
  • Permitted Purpose: Improves access to biologic treatments by developing alternative versions with similar effectiveness.
  • Technological in Nature: Uses biotechnology, protein engineering, and immunology.
  • Elimination of Uncertainty: Determines if a biosimilar can match the efficacy of the original biologic.
  • Process of Experimentation: Conducts comparative analytical testing, clinical equivalency trials, and stability studies.

Medical & Industrial Biotechnology

• Example: Advancing antibody-based therapies for infectious diseases and autoimmune disorders.
• 4-Part Test:
  • Permitted Purpose: Develops targeted therapies to enhance immune system responses.
  • Technological in Nature: Uses biotechnology, genetics, and bioinformatics.
  • Elimination of Uncertainty: Assesses whether engineered antibodies can effectively bind to specific disease targets.
  • Process of Experimentation: Conducts in-vitro binding studies, animal model testing, and clinical trials.

Genetic Engineering & CRISPR Technologies

• Example: Utilizing CRISPR gene-editing to develop treatments for genetic disorders such as sickle cell disease.
• 4-Part Test:
  • Permitted Purpose: Modifies defective genes to cure inherited diseases.
  • Technological in Nature: Uses genetic engineering, molecular biology, and bioinformatics.
  • Elimination of Uncertainty: Determines whether gene edits will be precise and effective without causing off-target effects.
  • Process of Experimentation: Conducts CRISPR delivery system testing, genetic screening, and preclinical trials.

Clinical Research Organizations (CROs)

• Example: Conducting clinical trials for pharmaceutical companies to evaluate drug safety and effectiveness.
• 4-Part Test:
  • Permitted Purpose: Supports drug development by ensuring safety and regulatory compliance.
  • Technological in Nature: Uses biomedical research, statistical analysis, and pharmacokinetics.
  • Elimination of Uncertainty: Determines the optimal dosage and potential side effects of new drugs.
  • Process of Experimentation: Runs double-blind studies, placebo-controlled trials, and real-world patient monitoring.

Vaccine Development

• Example: Engineering mRNA vaccines to enhance immune responses against viral infections.
• 4-Part Test:
  • Permitted Purpose: Advances vaccine efficacy and delivery mechanisms.
  • Technological in Nature: Uses virology, immunology, and genetic engineering.
  • Elimination of Uncertainty: Determines if modified mRNA sequences produce long-lasting immunity.
  • Process of Experimentation: Conducts formulation testing, immunogenicity assessments, and population-scale trials.

Regenerative Medicine & Tissue Engineering

• Example: Developing 3D bioprinted tissues for organ repair and medical research.
• 4-Part Test:
  • Permitted Purpose: Aims to create functional tissue replacements for damaged organs.
  • Technological in Nature: Uses bioengineering, cell biology, and material sciences.
  • Elimination of Uncertainty: Evaluates whether bioprinted tissues can integrate with the human body.
  • Process of Experimentation: Conducts in-vitro cell growth studies, biocompatibility testing, and preclinical animal trials.

Contact us to get started